12/06/2024
An optimal drug for chronic disease would slow down progression in the long term, with short-term symptomatic benefits. This would shorten clinical development timelines and reduce the cost and risk level for developers
An optimal drug for chronic neurological disease would slow down disease progression in the long term, with short-term symptomatic benefits